Table 1. Demographic and baseline clinical characteristics for patients with RA.
| Parameter | Total RA patients (n=63) | RA patients with remission (n=48) |
|---|---|---|
| Age (years) | 48.2±16.4 | 46.5±18.2 |
| Sex (male/female) | 16/47 | 9/39 |
| Disease duration (months) | 48.0±25.4 (range: 1–120) | |
| Duration of therapy (months) | 10.1±3.45 (range: 6–24) | |
| CRP (mg/L) | 39.51±16.24 (range: 3–116) | 5.58±2.35 (range: 1–9) |
| ESR (mm/h) | 55.36±25.93 (range: 6–147) | 17.09±15.42 (range: 3–48) |
| RF | 37.59±22.14 (range: 4–121) | 8.26±7.37 (range: 1–16) |
| ACPA positive, n (%) | 50 (79.4) | |
| SDAI | 2.78±0.39 (range: 1.9–3.2) |
The values are presented as mean ± standard deviation (SD). CRP <10 mg/L; ESR (male <15 mm/h, female <20 mm/h); RF <10. RA, rheumatoid arthritis; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; RF, rheumatoid factor; ACPA, anti-citrullinated protein antibody; SDAI, simplified disease activity index.